GTO ID | GTC2616 |
Trial ID | NCT04790747 |
Disease | Hematologic Cancer |
Therapy | CAR-T cell |
Treatment | CAR-T cells |
Phase | Phase1|Phase2 |
Recruitment status | Recruiting |
Title | Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions |
Year | 2021 |
Country | China |
Company sponsor | Zhejiang University |
Other ID(s) | EML-001 |
Cohort 1 | |||||||
|